These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 5580407)

  • 1. [Studies on the steroid-saving effect of oxyphenbutazone].
    Husmann F
    Dtsch Med Wochenschr; 1971 Jun; 96(24):1049-52. PubMed ID: 5580407
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cortisone withdrawal syndrome in progressive chronic polyarthritis and its management].
    Chlud K
    Biochim Biophys Acta; 1970 Jan; 198(1):59-66. PubMed ID: 5413945
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the pituitary-inhibiting action and pharmacokinetics of some synthetic corticosteroids].
    Fonzo D; Dogliotti L; De Martinis C; Cicchetti V
    Folia Endocrinol; 1969 Dec; 22(4):545-52. PubMed ID: 4329095
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical experiences with realin (oxyphenbutazone and prednisolone) in progressive chronic polyarthritis].
    Klein G; Fellner S
    Z Rheumaforsch; 1973; 32(7):302-5. PubMed ID: 4741803
    [No Abstract]   [Full Text] [Related]  

  • 5. [Evaluation of GP-40705 in rheumatoid arthritis].
    Badia Flores J
    Prensa Med Mex; 1969; 34(9):382-4. PubMed ID: 4907856
    [No Abstract]   [Full Text] [Related]  

  • 6. The rationale of alternate-day corticosteroid therapy.
    Jacobson ME
    Postgrad Med; 1971 Feb; 49(2):181-6. PubMed ID: 4322309
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical evaluation of corticoid administration of rheumatoid arthritis.
    Ballabio BC; Colombo B; Carrabba M
    Chronobiologia; 1974 Sep; 1 Suppl 1():388-93. PubMed ID: 4377965
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical experience with tandearil-prednisolone].
    Vidal Ferrandis J; Menchón Galiana M; López Dasí JL; López Prats JL
    Rev Esp Reum Enferm Osteoartic; 1975; 18(2):135-44. PubMed ID: 1144915
    [No Abstract]   [Full Text] [Related]  

  • 9. [Evaluation of the oxyphenylbutazone prednisolone combination in patients with progressive chronic polyarthritis].
    Pérez Gil L
    Rev Esp Reum Enferm Osteoartic; 1974; 17(1):45-52. PubMed ID: 4826156
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term anti-tumor necrosis factor antibody therapy in rheumatoid arthritis patients sensitizes the pituitary gland and favors adrenal androgen secretion.
    Straub RH; Pongratz G; Schölmerich J; Kees F; Schaible TF; Antoni C; Kalden JR; Lorenz HM
    Arthritis Rheum; 2003 Jun; 48(6):1504-12. PubMed ID: 12794817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dosage glucocorticoid therapy. An appraisal of its safety and mode of action in clinical disorders, including rheumatoid arthritis.
    Jefferies WM
    Arch Intern Med; 1967 Mar; 119(3):265-78. PubMed ID: 6019945
    [No Abstract]   [Full Text] [Related]  

  • 12. [In vivo investigation of the effect of antirheumatic drugs on DNA synthesis and DNA repair in patients with chronic rheumatoid arthritis (author's transl)].
    Tausch G; Tuschl P; Dunky A; Eberl R
    Wien Klin Wochenschr; 1974 Dec; 86(23):725-30. PubMed ID: 4439928
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of effects of corticotrophin and corticosteroids on pituitary-adrenal function.
    Carter ME; James VH
    Ann Rheum Dis; 1971 Jan; 30(1):91-7. PubMed ID: 4323367
    [No Abstract]   [Full Text] [Related]  

  • 14. [Results of cortisone withdrawal in 58 cases of rheumatoid polyarthritis].
    David-Chaussé J; Laporte G
    Rev Rhum Mal Osteoartic; 1968 Sep; 35(9):429-42. PubMed ID: 4301152
    [No Abstract]   [Full Text] [Related]  

  • 15. [Study of the efficacy and tolerance of oxyphenylbutazone-prednisone combination suppositories in rheumatology].
    Sariols M
    Rev Esp Reum Enferm Osteoartic; 1974; 17(3):242-51. PubMed ID: 4438806
    [No Abstract]   [Full Text] [Related]  

  • 16. [Which orthopedic indications are promising a successful therapy using Realin?].
    Sell G
    Z Allgemeinmed; 1972 Apr; 48(11):561-5. PubMed ID: 4537689
    [No Abstract]   [Full Text] [Related]  

  • 17. [The importance of studying steroid and hypophyseal hormone excretion in patients with dyshormonal tumors].
    Sharoukhova KS
    Vestn Akad Med Nauk SSSR; 1968; 23(3):63-8. PubMed ID: 5754742
    [No Abstract]   [Full Text] [Related]  

  • 18. Rheumatoid disease. Adrenocortical function and intermittent steroid therapy.
    Bilka PJ
    Minn Med; 1970 Feb; 53(2):143-8. PubMed ID: 5414437
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pharmacokinetic characteristics of 6 alpha-fluoroprednisolone].
    Castegnaro E; Sala G
    Folia Endocrinol; 1967 Jun; 20(3):367-82. PubMed ID: 5630807
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experiences with a new combination drug (Realin) in the treatment of acute rheumatic conditions].
    Siegmeth W; Herkner W
    Wien Med Wochenschr; 1974 Sep; 124(39):569-73. PubMed ID: 4409544
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.